Methimazole

Routes
Oral (PO)
Half-Life (t½)
PO: 5h
Formula
C4H6N2S
Molecular Weight
114.17 g/mol
PubChem CID
1349907
Aliases
Tapazole

Pharmacological Mechanism

Thionamide antithyroid — inhibits thyroid peroxidase (TPO) blocking iodination of thyroglobulin tyrosines → halts thyroid hormone synthesis. First-line for Graves disease + thyroid storm (after PTU in early pregnancy). Agranulocytosis is the feared adverse effect.

Half-Life & Elimination Curve (PO: 5h)

100%50%25%12.5%0%0h0×t½5h1×t½10h2×t½15h3×t½20h4×t½25h5×t½0×t½ (0h): 100% remaining (~0.254 mg/L)1×t½ (5h): 50% remaining (~0.127 mg/L)2×t½ (10h): 25% remaining (~63.4 µg/L)3×t½ (15h): 12.5% remaining (~31.7 µg/L)4×t½ (20h): 6.3% remaining (~15.9 µg/L)5×t½ (25h): 3.1% remaining (~7.93 µg/L)
Plasma (PO)t½ Decay (5h)
  • 0×t½0h100% (0.254 mg/L)
  • 1×t½5h50% (0.127 mg/L)
  • 2×t½10h25% (63.4 µg/L)
  • 3×t½15h12.5% (31.7 µg/L)
  • 4×t½20h6.3% (15.9 µg/L)
  • 5×t½25h3.1% (7.93 µg/L)
Elimination t½5h (PO)
Rate Constant (ke)0.139 h⁻¹
Time to Peak (Tmax)2.29h
Est. Peak (Cmax)0.254 mg/L
Clearance (CL)5.55 L/h
97% Washout (5×t½)25h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References